It began with a promise. CSL Behring's parent company, CSL, was formed more than 100 years ago to save lives using the latest technologies. In the century since, CSL Behring has grown into a global biotechnology leader, driven by that same promise to save and improve lives. We offer the broadest range of quality plasmaderived and recombinant therapies in our industry. Our ability to innovate and deliver lifesaving medicines for patients with rare disease and other unmet medical needs around the world has earned us a reputation for always putting patients first. We are CSL Behring and we are driven by our promise.

Learn more at http://www.CSLBehring.com

©2022 CSL Behring LLC
1020 First Avenue, King of Prussia, PA 19406, USA